Lipoprotein Metabolism in the Brain and Circulation and Its Role in Disease

The 2018 Lipoprotein Metabolism Gordon Research Conference (GRC) will be held at Waterville Valley Conference Center, NH on June 10-15, 2018. This interdisciplinary meeting will include not only the latest findings on the role of lipoprotein metabolism in cardiovascular disease, as in previous GRC meetings on this topic, but also how the field of lipoprotein research relates to neurodegenerative diseases. Thus, it will provide an opportunity for researchers in these two fields to interact in order to generate innovative questions and novel experimental approaches for both fields.

The Co-Chairs, Drs. Alan Remaley and Cheryl Wellington, in consultation with the past chair, the 2018 Vice Chairs (Drs. Mahmood Hussain and Kiran Musunuru), and field leaders, have planned nine oral sessions to promote dialogue among established and emerging leaders in cardiovascular disease and neurodegeneration: Keynote on New Pathways in Cellular Lipid Homeostasis in the Brain and Other Tissues, and Short Talks; Lipoprotein Metabolism in the Brain; Gut Microbiota and Intestinal Lipid Metabolism, and Short Talks; Tissue Engineering: New human experimental platforms for the study of metabolic disease; Genomics of Dementia and Cardiovascular Disease; HDL Structure and Function; ApoB-containing Lipoprotein Metabolism and Cellular Uptake Pathways; Novel Therapies and Diagnostic Approaches for Vascular Lipoprotein Disorders; Selected Poster Presentations and Late-Breaking Topics. The GRC will be preceded by the Lipoprotein Metabolism GRS, an international forum for presentation and discussion of frontier research by graduate students and postdoctoral fellows.